CPC
HAE icon

Cookson Peirce & Co’s Haemonetics HAE Stock Holding History

Cookson Peirce & Co’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-14,344
Closed -$1.13M – 232
2022
Q4 		$1.13M Sell
14,344
-998
-7% -$80.2K 0.07% 97
2022
Q3 		$1.14M Buy
+15,342
New +$1.1M 0.08% 96
2020
Q1 		– Sell
-136,101
Closed -$15.6M – 137
2019
Q4 		$15.6M Sell
136,101
-9,783
-7% -$1.18M 1.38% 27
2019
Q3 		$18.4M Buy
145,884
+84,609
+138% +$10.7M 1.61% 23
2019
Q2 		$7.37M Buy
+61,275
New +$6.03M 0.62% 51

Other funds holding HAE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cookson Peirce & Co's HAE Position: Q1 2023 in Review

Cookson Peirce & Co sold out of Haemonetics (HAE) in Q1 2023, closing a stake of 14,344 shares — an estimated $1.13M sold.

Cookson Peirce & Co first reported a position in HAE in Q2 2019 and held it in 5 quarters. The position peaked at $18.4M in Q3 2019. 301 funds tracked by Wall St. Rank hold HAE as of Q1 2023.

  • Cookson Peirce & Co reported no remaining Haemonetics position as of Q1 2023 after selling out during the quarter.
  • Cookson Peirce & Co sold 14,344 Haemonetics shares in Q1 2023, an estimated $1.13M.
  • Cookson Peirce & Co first reported a position in Haemonetics in Q2 2019 and held it in 5 quarters.
  • Cookson Peirce & Co's Haemonetics position peaked at $18.4M in Q3 2019.
  • 301 funds tracked by Wall St. Rank held Haemonetics as of Q1 2023.

Based on Cookson Peirce & Co's 13F filing for Q1 2023, filed 3 May 2023.